Welcome to AGILE R100
Reliable biophysical characterization, at your fingertips.
The easy-to-learn AGILE R100 assay makes it simple to get dose-response curves and kinetic binding data earlier in the drug discovery process when you need it most. Built with highly sensitive, proprietary Field Effect Biosensing (FEB) technology, AGILE R100 enables detection even in crude samples using minimal volume, giving you control over the complete characterization of your biomolecules.
Optimize leads with a novel label-free method and achieve measurements never before possible!
SENSITIVE LABEL-FREE RESULTS WITH AGILE R100
AGILE R100’s open-pipetting design enables on-the-fly assay modification, vastly reducing assay development time.
See how it’s used in this 1:32 video!
Join us to learn more about the AGILE R100 orthogonal approach to biophysical characterization at one of these events!
Our VP Production, Dr. Mitchell Lerner, will present a talk about the commercial fabrication of graphene biosensors at the 2017 Materials Research Society (MRS) Spring Meeting on Apr. 19 in Phoenix. Join us!